Clinical Trial Update: Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adipose tissue–derived mesenchymal stem cells as an osteogenic component in composite grafts for osteoporotic fractures has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Osteoporotic Fracture

Drugs mentioned

• Adipose tissue-derived mesenchymal stem cells (adipose tissue-derived mesenchymal stem cells)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Osteoporotic Fractures | Phase 2 | Status: TERMINATED